Multiple HLA class I and II associations in classical Hodgkin lymphoma and EBV status defined subgroups

Blood

Volumn 118, Issue 19, 2011, Pages 5211-5217

  Huang, Xin ^a,b   Kushekhar, Kushi ^a   Nolte, Ilja ^c   Kooistra, Wierd ^a   Visser, Lydia ^a   Bouwman, Ilby ^c   Kouprie, Niels ^c   Veenstra, Rianne ^a   Van Imhoff, Gustaaf ^a   Olver, Bianca ^d   Houlston, Richard S ^d   Poppema, Sibrand ^a   Diepstra, Arjan ^a   Hepkema, Bouke ^c   Van Den Berg, Anke ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A1 ANTIGEN; HLA A11 ANTIGEN; HLA A2 ANTIGEN; HLA A3 ANTIGEN; HLA A68 ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B37 ANTIGEN; HLA CW6 ANTIGEN; HLA DR10 ANTIGEN; HLA DR11 ANTIGEN; HLA DR15 ANTIGEN; HLA DR4 ANTIGEN; HLA DR7 ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PATIENT; CASE CONTROL STUDY; CLASSICAL HODGKIN LYMPHOMA; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 81155151870     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-04-342998     Document Type: Article

References (31)

1. Landgren O, Caporaso NE. New aspects in descriptive, etiologic, and molecular epidemiology of Hodgkin's lymphoma. Hematol Oncol Clin North Am. 2007;21(5):825-840. (Pubitemid 47496094)
2. Kuppers R. The biology of Hodgkin's lymphoma. Nat Rev Cancer. 2009;9(1):15-27.
3. Sonmez M, Erkut N, Ucar F, et al. Familial Hodgkin's lymphoma from the perspective of HLA. Intern Med. 2010;49(6):607-610.
4. Cartwright RA, Watkins G. Epidemiology of Hodgkin's disease: a review. Hematol Oncol. 2004;22(1):11-26. (Pubitemid 38724548)
5. Diepstra A, Niens M, Vellenga E, et al. Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus- negative Hodgkin's lymphoma. Lancet. 2005;365(9478):2216-2224. (Pubitemid 40853915)
6. Diepstra A, Niens M, Te Meerman GJ, Poppema S, van den Berg A. Genetic susceptibility to Hodgkin's lymphoma associated with the human leukocyte antigen region. Eur J Haematol Suppl. 2005;66:34-41. (Pubitemid 40879619)
7. Harty LC, Lin AY, Goldstein AM, et al. HLA-DR, HLA-DQ, and TAP genes in familial Hodgkin disease. Blood. 2002;99(2):690-693. (Pubitemid 34533109)
8. Depil S, Morales O, Auriault C. Hodgkin's disease and Epstein-Barr virus. Ann Biol Clin (Paris). 2004;62(6):639-648. (Pubitemid 39568580)
9. Lee SP, Tierney RJ, Thomas WA, Brooks JM, Rickinson AB. Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy. J Immunol. 1997;158(7):3325-3334. (Pubitemid 127484050)
10. Voo KS, Fu T, Wang HY, et al. Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes. J Exp Med. 2004;199(4):459-470. (Pubitemid 38233830)
11. Kruger S, Schroers R, Rooney CM, Gahn B, Chen SY. Identification of a naturally processed HLA-DR-restricted T-helper epitope in Epstein- Barr virus nuclear antigen type 1. J Immunother. 2003;26(3):212-221. (Pubitemid 36686890)
12. Marshall WH, Barnard JM, Buehler SK, Crumley J, Larsen B. HLA in familial Hodgkin's disease: results and a new hypothesis. Int J Cancer. 1977;19(4):450-455. (Pubitemid 8073394)
13. Hansen JA, Young CW, Whitsett C, et al. HLA and MLC typing in patients with Hodgkin's disease. Prog Clin Biol Res. 1977;16:217-227.
14. Hafez MM, el-Wehedy GF, el-Kholy NM, et al. The value of HLA phenotypes in the prognosis of Hodgkin's lymphoma. Int J Cancer. 1985;36(1):19-22. (Pubitemid 15028609)
15. Niens M, van den Berg A, Diepstra A, et al. The human leukocyte antigen class I region is associated with EBV-positive Hodgkin's lymphoma: HLA-A and HLA complex group 9 are putative candidate genes. Cancer Epidemiol Biomarkers Prev. 2006;15(11):2280-2284. (Pubitemid 44877057)
16. Niens M, Jarrett RF, Hepkema B, et al. HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma. Blood. 2007;110(9):3310-3315. (Pubitemid 350106324)
17. Hjalgrim H, Rostgaard K, Johnson PC, et al. HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma. Proc Natl Acad Sci U S A. 2010;107(14):6400-6405.
18. Enciso-Mora V, Broderick P, Ma Y, et al. A genome-wide association study of Hodgkin lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21, and 10p14 (GATA3). Nat Genet. 2010;42(12):1126-1130.
19. Helmberg W, Lanzer G, Zahn R, et al. Virtual DNA analysis: a new tool for combination and standardised evaluation of SSO, SSP and sequencing- based typing results. Tissue Antigens. 1998;51(4):587-592. (Pubitemid 28306462)
20. Bjorkman PJ, Parham P. Structure, function, and diversity of class I major histocompatibility complex molecules. Annu Rev Biochem. 1990;59:253-288.
21. Cano P, Klitz W, Mack SJ, et al. Common and well-documented HLA alleles: report of the Ad- Hoc committee of the American Society for Histocompatiblity and Immunogenetics. Hum Immunol. 2007;68(5):392-417. (Pubitemid 46616982)
22. Stephens M, Scheet P. Accounting for decay of linkage disequilibrium in haplotype inference and missing data imputation. Am J Hum Genet. 2005;76(3):449-462. (Pubitemid 40250525)
23. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001;68(4):978-989. (Pubitemid 32289743)
24. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559-575. (Pubitemid 47330214)
25. Ghodke Y, Joshi K, Chopra A, Patwardhan B. HLA and disease. Eur J Epidemiol. 2005;20(6):475-488. (Pubitemid 40933924)
26. Rickinson AB, Moss DJ. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu Rev Immunol. 1997;15:405-431. (Pubitemid 27169287)
27. Hildesheim A, Apple RJ, Chen CJ, et al. Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst. 2002;94(23):1780-1789. (Pubitemid 36004354)
28. Burt RD, Vaughan TL, McKnight B, et al. Associations between human leukocyte antigen type and nasopharyngeal carcinoma in Caucasians in the United States. Cancer Epidemiol Biomarkers Prev. 1996;5(11):879-887. (Pubitemid 26382981)
29. Gavioli R, de Campos-Lima PO, Kurilla MG, et al. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11- restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma. Proc Natl Acad Sci U S A. 1992;89(13):5862-5866.
30. Murray RJ, Wang D, Young LS, et al. Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP. J Virol. 1988;62(10):3747-3755.
31. Robertson SJ, Lowman JT, Grufferman S, et al. Familial Hodgkin's disease: a clinical and laboratory investigation. Cancer. 1987;59(7):1314-1319. (Pubitemid 17035477)